Evaxion Biotech A/S

EVAX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$5,052$5,583$13,184$32,166
Short-Term Investments$0$0$0$0
Receivables$1,858$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,855$2,767$3,801$2,539
Total Curr. Assets$8,765$8,350$16,985$34,705
Property Plant & Equip (Net)$3,514$4,343$4,675$5,174
Goodwill$0$0$0$0
Intangibles$0$0$0$93
Long-Term Investments$44$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$162$196$365$191
Total NC Assets$3,720$4,539$5,040$5,458
Other Assets$0$0$0$0
Total Assets$12,485$12,889$22,025$40,163
Liabilities
Payables$2,968$2,689$2,085$2,848
Short-Term Debt$473$485$439$440
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$927$3,910$1,238$1,035
Total Curr. Liab.$4,368$7,084$3,762$4,323
LT Debt$9,628$10,385$9,816$3,250
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$141$149$144$153
Total NC Liab.$9,769$10,534$9,960$3,403
Other Liabilities$0$0$0$0
Cap. Leases$1,934$2,222$2,255$2,520
Total Liabilities$14,137$17,618$13,722$7,726
Equity
Pref Stock$0$0$0$0
Common Stock$10,516$5,899$3,886$3,755
Retained Earnings-$118,539-$107,970-$85,845-$50,432
AOCI-$3,595$9,892$9,535-$1,316
Other Equity$109,966$87,450$80,727$80,430
Total Equity-$1,652-$4,729$8,303$32,437
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$12,485$12,889$22,025$40,163
Net Debt$5,049$5,287-$2,929-$28,476